Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective decreased by BTIG Research from $134.00 to $126.00 in a research report sent to investors on Thursday morning, Benzinga reports. BTIG Research currently has a buy rating on the medical equipment provider’s stock. ZBH has been the topic of a number of other research reports. […]

Guidewire Software (NYSE:GWRE – Free Report) had its target price boosted by JPMorgan Chase & Co. from $170.00 to $210.00 in a research report released on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the technology company’s stock. A number of other brokerages also recently issued reports on GWRE. Robert […]

Jefferies Financial Group reiterated their buy rating on shares of Novavax (NASDAQ:NVAX – Free Report) in a report issued on Wednesday, Benzinga reports. They currently have a $31.00 price target on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on NVAX. JPMorgan Chase & Co. upped their target price […]

Macquarie assumed coverage on shares of ZEEKR Intelligent Technology (NYSE:ZK – Free Report) in a report published on Thursday, MarketBeat Ratings reports. The firm issued an outperform rating and a $33.00 price target on the stock. Several other analysts have also recently issued reports on the stock. Citigroup initiated coverage on shares of ZEEKR Intelligent […]

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They currently have a $65.00 target price on the biopharmaceutical company’s stock. HC Wainwright’s target price points to a potential upside of 9.83% from the company’s […]

Guidewire Software (NYSE:GWRE – Free Report) had its price target increased by Wells Fargo & Company from $185.00 to $200.00 in a research report report published on Thursday, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the technology company’s stock. GWRE has been the subject of several other research reports. Oppenheimer […]

StockNews.com lowered shares of Marvell Technology (NASDAQ:MRVL – Free Report) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning. Several other research firms also recently weighed in on MRVL. Rosenblatt Securities lifted their target price on Marvell Technology from $100.00 to $120.00 and gave the company […]

Arista Networks (NYSE:ANET – Free Report) had its price target upped by Evercore ISI from $400.00 to $425.00 in a report published on Tuesday, Benzinga reports. The firm currently has an outperform rating on the technology company’s stock. A number of other research analysts have also recently commented on ANET. The Goldman Sachs Group upped […]

Jefferies Financial Group restated their buy rating on shares of Novavax (NASDAQ:NVAX – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $31.00 price target on the biopharmaceutical company’s stock. A number of other analysts have also recently commented on NVAX. B. Riley reiterated a buy rating and set […]

EQT (NYSE:EQT – Get Free Report) was upgraded by research analysts at Citigroup from a “neutral” rating to a “buy” rating in a report released on Thursday, Marketbeat.com reports. The brokerage presently has a $44.00 price target on the oil and gas producer’s stock, up from their previous price target of $37.00. Citigroup’s price target […]

Integra LifeSciences (NASDAQ:IART – Free Report) had its price objective decreased by Citigroup from $20.00 to $16.00 in a research note released on Tuesday morning, Benzinga reports. Citigroup currently has a sell rating on the life sciences company’s stock. IART has been the topic of a number of other reports. Morgan Stanley increased their price […]

TE Connectivity (NYSE:TEL – Free Report) had its price target trimmed by The Goldman Sachs Group from $189.00 to $179.00 in a report published on Tuesday, Benzinga reports. The firm currently has a buy rating on the electronics maker’s stock. TEL has been the topic of several other research reports. Wells Fargo & Company cut […]

Guidewire Software (NYSE:GWRE – Get Free Report) had its price objective upped by equities research analysts at JPMorgan Chase & Co. from $170.00 to $210.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the technology company’s stock. JPMorgan Chase & Co.‘s price target would indicate a […]

Guidewire Software (NYSE:GWRE – Get Free Report) had its price objective boosted by research analysts at Wells Fargo & Company from $185.00 to $200.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has an “overweight” rating on the technology company’s stock. Wells Fargo & Company‘s price objective points to […]

Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price target dropped by research analysts at BTIG Research from $134.00 to $126.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the medical equipment provider’s stock. BTIG Research’s price objective would suggest a potential upside of […]